Tech Company Financing Transactions

Anocca Funding Round

Anocca, based in Södertälje, secured $26.6 million in funding from European Investment Bank.

Transaction Overview

Company Name
Announced On
12/21/2022
Transaction Type
Debt
Amount
$26,640,000
Round
Undisclosed
Investors

European Investment Bank (Lead Investor)

Proceeds Purpose
Our financing will help to accelerate clinical development to provide patients with access to innovative therapies in areas of high unmet medical need. This support confirms EIB's role as a leading investor in innovation and life sciences and boosts Europe's competitiveness and role as a research powerhouse

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Forskargatan 20C
Södertälje, 151 36
SE
Email Address
Overview
Anocca is a privately held Swedish biotechnology company founded in 2014 with the mission to establish a unique technology platform for analysis of T-cell biology to unlock the therapeutic potential of T-cell immunity. Anocca's technologies enable the highly precise and efficient analysis of T-cell biology required to deliver a range of therapeutics that specifically harness or manipulate T-cell immunity in a number of disease areas. With a focus on delivering TCR-modified T-cell therapies (TCR-T) in oncology, Anocca is rapidly progressing a pipeline of novel T-cell therapies towards clinical trials utilizing our own manufacturing capabilities.
Profile
Anocca LinkedIn Company Profile
Social Media
Anocca Company Twitter Account
Company News
Anocca News
Facebook
Anocca on Facebook
YouTube
Anocca on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Reagan Jarvis
  Reagan Jarvis LinkedIn Profile  Reagan Jarvis Twitter Account  Reagan Jarvis News  Reagan Jarvis on Facebook
Chief Financial Officer
Jacob Michlewicz
  Jacob Michlewicz LinkedIn Profile  Jacob Michlewicz Twitter Account  Jacob Michlewicz News  Jacob Michlewicz on Facebook
Chief Information Officer
Ryan Hill
  Ryan Hill LinkedIn Profile  Ryan Hill Twitter Account  Ryan Hill News  Ryan Hill on Facebook
Chief Operating Officer
Viktor Arnkil
  Viktor Arnkil LinkedIn Profile  Viktor Arnkil Twitter Account  Viktor Arnkil News  Viktor Arnkil on Facebook
Chief Scientific Officer
Hugh Salter
  Hugh Salter LinkedIn Profile  Hugh Salter Twitter Account  Hugh Salter News  Hugh Salter on Facebook
Chief Technical Officer
Luke Pase
  Luke Pase LinkedIn Profile  Luke Pase Twitter Account  Luke Pase News  Luke Pase on Facebook


 

 

Browse more venture capital transactions:

Prev: 12/21/2022: Fiscozen venture capital transaction
Next: 12/21/2022: Treblle venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on every notable VC transaction. VC transactions reported here come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary